A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
Clin Pharmacol Ther. 1995 Oct;58(4):444-52. doi: 10.1016/0009-9236(95)90058-6.
Clin Pharmacol Ther. 1995.
PMID: 7586937
Clinical Trial.